Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GELF-94 Study for Follicular Lymphoma
NCT00140569Phase 3Completed
- Sponsor
- Lymphoma Study Association
- Start
- Jan 1994
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
A Phase 3 trial of fludarabine in follicular lymphoma (FL), sponsored by Lymphoma Study Association. Started Jan 1994; status: completed.
02
Drugs
fludarabine
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00140569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00140569.